Skip to main content

NATIXIS ADVISORS, LLC

Position in TEVA — Teva Pharmaceutical Industries Ltd

CIK 1018331 Boston, MA

Position in TEVA

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$17,043,763
+$7,920,924 QoQ
Shares Held
565,862
+93.6% QoQ
Ownership
0.049%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in TEVA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

NATIXIS ADVISORS, LLC holds $166,492,947 across 17 Drug Manufacturers - Specialty & Generic names. TEVA ranks #2 (10.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 TEVA
Teva Pharmaceutical Industries Ltd
This page
565,862 $17,043,763

All Filings in TEVA

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $17,043,763 565,862
2025-12-31 $9,122,839 292,305
2025-09-30 $5,528,719 273,699
2025-06-30 $6,456,203 385,215
2025-03-31 $5,117,026 332,923
2024-12-31 $11,119,929 504,534
2024-09-30 $3,042,983 168,867
2024-06-30 $3,271,970 201,352
2024-03-31 $2,229,083 157,979